130 related articles for article (PubMed ID: 32713862)
21. Inactivating Three Interferon Antagonists Attenuates Pathogenesis of an Enteric Coronavirus.
Deng X; Buckley AC; Pillatzki A; Lager KM; Faaberg KS; Baker SC
J Virol; 2020 Aug; 94(17):. PubMed ID: 32554697
[TBL] [Abstract][Full Text] [Related]
22. Development of a Fluorescence-Based, High-Throughput SARS-CoV-2 3CL
Froggatt HM; Heaton BE; Heaton NS
J Virol; 2020 Oct; 94(22):. PubMed ID: 32843534
[TBL] [Abstract][Full Text] [Related]
23. Extreme Genomic CpG Deficiency in SARS-CoV-2 and Evasion of Host Antiviral Defense.
Xia X
Mol Biol Evol; 2020 Sep; 37(9):2699-2705. PubMed ID: 32289821
[TBL] [Abstract][Full Text] [Related]
24. Improved Molecular Diagnosis of COVID-19 by the Novel, Highly Sensitive and Specific COVID-19-RdRp/Hel Real-Time Reverse Transcription-PCR Assay Validated
Chan JF; Yip CC; To KK; Tang TH; Wong SC; Leung KH; Fung AY; Ng AC; Zou Z; Tsoi HW; Choi GK; Tam AR; Cheng VC; Chan KH; Tsang OT; Yuen KY
J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32132196
[TBL] [Abstract][Full Text] [Related]
25. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States.
Harcourt J; Tamin A; Lu X; Kamili S; Sakthivel SK; Murray J; Queen K; Tao Y; Paden CR; Zhang J; Li Y; Uehara A; Wang H; Goldsmith C; Bullock HA; Wang L; Whitaker B; Lynch B; Gautam R; Schindewolf C; Lokugamage KG; Scharton D; Plante JA; Mirchandani D; Widen SG; Narayanan K; Makino S; Ksiazek TG; Plante KS; Weaver SC; Lindstrom S; Tong S; Menachery VD; Thornburg NJ
Emerg Infect Dis; 2020 Jun; 26(6):1266-1273. PubMed ID: 32160149
[TBL] [Abstract][Full Text] [Related]
26. Isolation of infectious SARS-CoV-2 from urine of a COVID-19 patient.
Sun J; Zhu A; Li H; Zheng K; Zhuang Z; Chen Z; Shi Y; Zhang Z; Chen SB; Liu X; Dai J; Li X; Huang S; Huang X; Luo L; Wen L; Zhuo J; Li Y; Wang Y; Zhang L; Zhang Y; Li F; Feng L; Chen X; Zhong N; Yang Z; Huang J; Zhao J; Li YM
Emerg Microbes Infect; 2020 Dec; 9(1):991-993. PubMed ID: 32342724
[TBL] [Abstract][Full Text] [Related]
27. COVID-19: a conundrum to decipher.
Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
[TBL] [Abstract][Full Text] [Related]
28. Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference.
Zhang Y; Li T; Fu L; Yu C; Li Y; Xu X; Wang Y; Ning H; Zhang S; Chen W; Babiuk LA; Chang Z
FEBS Lett; 2004 Feb; 560(1-3):141-6. PubMed ID: 14988013
[TBL] [Abstract][Full Text] [Related]
29. Global Initiative Seeks to Crack the COVID-19 Genetic Code.
Am J Med Genet A; 2020 Sep; 182(9):1998-1999. PubMed ID: 32881367
[No Abstract] [Full Text] [Related]
30. Are Viral Vectors Any Good for RNAi Antiviral Therapy?
Lundstrom K
Viruses; 2020 Oct; 12(10):. PubMed ID: 33092124
[TBL] [Abstract][Full Text] [Related]
31. SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Cells; 2021 Jun; 10(6):. PubMed ID: 34201214
[TBL] [Abstract][Full Text] [Related]
32. Isolation and characterization of severe acute respiratory syndrome coronavirus 2 in Turkey.
Pavel STI; Yetiskin H; Aydin G; Holyavkin C; Uygut MA; Dursun ZB; Celik İ; Cevik C; Ozdarendeli A
PLoS One; 2020; 15(9):e0238614. PubMed ID: 32936826
[TBL] [Abstract][Full Text] [Related]
33. SARS-CoV-2 and the safety margins of cell-based biological medicinal products.
Modrof J; Kerschbaum A; Farcet MR; Niemeyer D; Corman VM; Kreil TR
Biologicals; 2020 Nov; 68():122-124. PubMed ID: 32891497
[TBL] [Abstract][Full Text] [Related]
34. Characterization and Noncovalent Inhibition of the Deubiquitinase and deISGylase Activity of SARS-CoV-2 Papain-Like Protease.
Freitas BT; Durie IA; Murray J; Longo JE; Miller HC; Crich D; Hogan RJ; Tripp RA; Pegan SD
ACS Infect Dis; 2020 Aug; 6(8):2099-2109. PubMed ID: 32428392
[TBL] [Abstract][Full Text] [Related]
35. Rapid production of SARS-CoV-2 receptor binding domain (RBD) and spike specific monoclonal antibody CR3022 in Nicotiana benthamiana.
Rattanapisit K; Shanmugaraj B; Manopwisedjaroen S; Purwono PB; Siriwattananon K; Khorattanakulchai N; Hanittinan O; Boonyayothin W; Thitithanyanont A; Smith DR; Phoolcharoen W
Sci Rep; 2020 Oct; 10(1):17698. PubMed ID: 33077899
[TBL] [Abstract][Full Text] [Related]
36. Host Immune Response Driving SARS-CoV-2 Evolution.
Wang R; Hozumi Y; Zheng YH; Yin C; Wei GW
Viruses; 2020 Sep; 12(10):. PubMed ID: 32992592
[TBL] [Abstract][Full Text] [Related]
37. International Expansion of a Novel SARS-CoV-2 Mutant.
Wang M; Li M; Ren R; Li L; Chen EQ; Li W; Ying B
J Virol; 2020 Jun; 94(12):. PubMed ID: 32269121
[No Abstract] [Full Text] [Related]
38. Emergence of a Novel Coronavirus, Severe Acute Respiratory Syndrome Coronavirus 2: Biology and Therapeutic Options.
Khan S; Siddique R; Shereen MA; Ali A; Liu J; Bai Q; Bashir N; Xue M
J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32161092
[TBL] [Abstract][Full Text] [Related]
39. Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach.
Naqvi AAT; Fatima K; Mohammad T; Fatima U; Singh IK; Singh A; Atif SM; Hariprasad G; Hasan GM; Hassan MI
Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165878. PubMed ID: 32544429
[TBL] [Abstract][Full Text] [Related]
40. Inflammation, Thrombosis, and Destruction: The Three-Headed Cerberus of Trauma- and SARS-CoV-2-Induced ARDS.
Lupu L; Palmer A; Huber-Lang M
Front Immunol; 2020; 11():584514. PubMed ID: 33101314
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
